Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 6/20 | 0.61 |
| ▸ | CCKBR | P32239 | 1/20 | 0.60 |
| ▸ | PTH1R | Q03431 | 9/20 | 0.60 |
| ▸ | ECE1 | P42892 | 1/20 | 0.59 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.59 |
| ▸ | NR3C1 | P04150 | 5/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2759455 | 0.87 | NR3C1 (0.70) | GLP1RCCKBRPTH1RECE1MUS81 | |
| SCHEMBL2742706 | 0.87 | NR3C1 (0.70) | GLP1RCCKBRPTH1RECE1MUS81 | |
| SCHEMBL5959058 | 0.86 | GLP1R (0.68) | GLP1RCCKBRPTH1RECE1MUS81 | |
| SCHEMBL10083215 | 0.85 | GLP1R (0.70) | GLP1RCCKBRECE1MUS81NR3C1 | |
| SCHEMBL2752275 | 0.84 | GLP1R (0.70) | GLP1RCCKBRECE1MUS81NR3C1 | |
| SCHEMBL6123960 | 0.83 | GLP1R (0.69) | GLP1RCCKBRECE1MUS81NR3C1 | |
| SCHEMBL15024692 | 0.83 | GLP1R (0.67) | GLP1RCCKBRECE1MUS81NR3C1 | |
| SCHEMBL12873154 | 0.83 | GLP1R (0.67) | GLP1RCCKBRECE1MUS81NR3C1 | |
| SCHEMBL29412274 | 0.83 | GLP1R (0.73) | GLP1RCCKBRPTH1RECE1MUS81 | |
| SCHEMBL15086005 | 0.82 | GLP1R (0.67) | GLP1RCCKBRECE1MUS81NR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8828994-B2 | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof | SANOFI (FR) | 2014-09-09 | — | — | US | disclosed |